How much does Pharmaron Biologics (UK) Ltd make?

Pharmaron Biologics (UK) Ltd reported revenue of £27.9m and a loss of £311k in the year to 31 Dec 2024, according to its accounts filed at Companies House.

How many employees does Pharmaron Biologics (UK) Ltd have?

Pharmaron Biologics (UK) Ltd reported an average of 187 employees in the year to 31 Dec 2024.

Is Pharmaron Biologics (UK) Ltd profitable?

No — Pharmaron Biologics (UK) Ltd reported a loss of £311k in the year to 31 Dec 2024.

Company No. 04543737 · Incorporated 24 Sep 2002

Pharmaron Biologics (UK) Ltd

Registered name: PHARMARON BIOLOGICS (UK) LTD

Part of Pharmaron Biologics (UK) Holdings Limited group

Pharmaron Biologics (UK) Ltd made £27.9m revenue and a £311k loss in the year to 31 Dec 2024. read from filing text

Pharmaron Biologics (UK) Ltd’s revenue fell 5% to £27.9m in the year to 31 Dec 2024, with a loss of £311k and 187 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Liverpool; we hold 2 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products

Status: Active
Location: Liverpool, North West
Age: 24 yrs · since 2002
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The Company is indirectly majority-owned by Pharmaron Beijing Co., Ltd., which is dual-listed on the Shenzhen Stock Exchange (stock code: 300759.SZ) and the Main Board of the Stock Exchange of Hong Ko”

Latest accounts · year to 31 Dec 2024

Key figures

Revenue

£27.9m

Growth ▼4.9%

Profit

−£311k

Growth —

Profit margin

−1.1%

Gross 33.9%

Employees

187

Change ▲2.2%

Profit / employee

−£1.7k

Revenue/employee £149k

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2023	31 Dec 2024
Disclosure	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	£29.3m	£27.9m
Cost of sales	£20.2m	£18.5m
Gross profit	£9.2m	£9.5m
Operating profit	−£1.1m	−£694k
Profit before tax	−£1m	−£311k
Profit (best available)	−£1m	−£311k
Staff costs	£14.2m	£14.2m
Employees (average)	183	187
Ratios
Profit margin	−3.4%	−1.1%
Gross margin	31.3%	33.9%
Revenue per employee	£160k	£149k
Profit per employee	−£5.5k	−£1.7k
Growth (year on year)
Revenue growth	—	▼4.9%
Headcount growth	—	▲2.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£11.1m	£11.8m
Net assets	£59.9m	£75.7m
Deferred income	£8.2m	£8.2m
Source	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Sep 2025

Derived from the latest filing

How the business works

Profit margin: −1.1%; Profit ÷ revenue.
Gross margin: 33.9%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £149k; Revenue ÷ average employees.
Profit per employee: −£1.7k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 29.2%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲26%; Now £75.7m
Cash at bank: ▲7%; Now £11.8m
Headcount: ▲2%; Now 187
Deferred income: ▼1%; Now £8.2m
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Pharmaron Biologics (UK) Holdings Limitedultimate parent75–100%
Pharmaron Biologics (UK) Ltdthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit −£311k), from the Companies House accounts bulk data published Sep 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.